JCRB9085 P3X63Ag8U.1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB9085 | Cell Name | P3X63Ag8U.1 |
---|---|---|---|
Profile | myeloma, plasmacytoma, 8-azaguanine resistant, (BALB/c mouse) | Other Name | |
Animal | mouse | Strain | BALB/C |
Genus | Mus | Species | musclus |
Sex | Age | ||
Identity | Tissue for Primary Cancer | hemo-lymphocytic | |
Case history | Metastasis | ||
Tissue Metastasized | Genetics | myeloma derivative | |
Life Span | Crisis PDL | ||
Morphology | Character | myeloma derivative | |
Classify | Established by | Kohler & Milstein | |
Registered by | Regulation for Distribution | Following rules from ATCC | |
Comment | Prepared from CRL1597. | Year | 1985 |
Medium | DMEM + 4.5g/L glucose + NEAA + FCS 10% | Methods for Passages | Dilution. A density of 1-1.5x10^6/ml should not be exceeded. |
Cell Number on Passage | 3-5 x 10^5/ml | Race | |
CO2 Conc. | 5 % | Tissue Sampling | plasmacytoma |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | not tested | Detected RNA Virus | not tested |
Reference | |
---|---|
Pubmed id:3500068 | Reciprocal effects of epidermal growth factor and transforming growth factor beta on the anchorage-dependent and -independent growth of A431 epidermoid carcinoma cells. Lee K,Tanaka M,Hatanaka M,Kuze F Exp Cell Res. 1987 Nov;173(1):156-62 |
Pubmed id:113458 | A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. Kearney JF,Radbruch A,Liesegang B,Rajewsky K J Immunol. 1979 Oct;123(4):1548-50 |
Pubmed id:74805 | Hybrid cell lines secreting monoclonal antibody specific for major histocompatibility antigens of the mouse. Lemke H,Hammerling GJ,Hohmann C,Rajewsky K Nature. 1978 Jan 19;271(5642):249-51 |
Pubmed id:567551 | Fusion of mouse myeloma and spleen cells. Yelton DE,Diamond BA,Kwan SP,Scharff MD Curr Top Microbiol Immunol. 1978;81():1-7 |
Pubmed id:268647 | Production of antibodies against influenza virus by somatic cell hybrids between mouse myeloma and primed spleen cells. Koprowski H,Gerhard W,Croce CM Proc Natl Acad Sci U S A. 1977 Jul;74(7):2985-8 |
Pubmed id:1172191 | Continuous cultures of fused cells secreting antibody of predefined specificity. Köhler G,Milstein C Nature. 1975 Aug 7;256(5517):495-7 |
LOT Information
Cell No. | JCRB9085 | Cell Name | |
---|---|---|---|
LOT No. | 03142002 | Lot Specification | distribution |
Medium | Dulbecco's modified Eagle's medium (4.5 g/L glucose), non-essential amino acids, and 10% fetal bovine serum | Temperature | 37 C |
Cell Density at Seeding | 1-2 x 10^5 cells/ml | Methods for Passages | Dilution |
Doubling Time | D.T. = ca 18 hrs | Cell Number in Vial (cells/1ml) | 3.0 x 10^6 |
Viability at cell freezing (%) | 82 | Antibiotics Used | free |
Passage Number | Unknown (5 at cellbank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as mouse by NP, G6PD, MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | No | Exoteric Gene | |
Medium for Freezing | culture medium with 10% DMSO, 20% FBS | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB9085 | Cell Name | P3X63Ag8U.1 |
---|---|---|---|
LOT No. | 111688 | Lot Specification | distribution |
Medium | DMEM,4.5g/L glucose,non essen amino acids + FCS10% | Temperature | 37 |
Cell Density at Seeding | 3-5 x 10^5/ml | Methods for Passages | Dilution. A density of 1-1.5x10^6/ml should not be exceeded. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 9.7x10^6 |
Viability at cell freezing (%) | NT | Antibiotics Used | free |
Passage Number | *P4 | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | LD |
Chromosome Mode | Chromosome Information | NT | |
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | CO2 Conc. | ||
Viability immediately after thawing (%) | Additional information |